Noyori’s

In cases where Noyori s reagent (see p. 102f.) and other enantioselective reducing agents are not successful, (+)- or (—)-chlorodiisopinocampheylborane (Ipc BCl) may help. This reagent reduces prochiral aryl and tert-alkyl ketones with exceptionally high enantiomeric excesses (J. Chandrasekharan, 1985 H.C. Brown, 1986). The initially formed boron moiety is usually removed hy precipitation with diethanolamine. Ipc2BCl has, for example, been applied to synthesize polymer-supported chiral epoxides with 90% e.e. from Merrifield resins (T. Antonsson, 1989). 

R. Noyori, S. Suga, K. Kawai, S. Okada, M. Kitamura, Pure Appl. Chem. 60, 1597 (1988). 

In 1998, two other examples of chiral ligands that enabled the asymmetric addition of organozinc reagents to ketones were reported by two groups independently. Thus, Dosa and Fu employed the nonsulfur-containing Noyori s DAIB " ligand in the asymmetric addition of ZnPh2 to ketones with... 

As another successful application of Noyori s TsDPEN ligand, Yan et al. reported the synthesis of antidepressant duloxetine, in 2008. Thus, the key step of this synthesis was the asymmetric transfer hydrogenation of 3-(dime-thylamino)-l-(thiophen-2-yl)propan-l-one performed in the presence of (5,5)-TsDPEN Ru(II) complex and a HCO2H TEA mixture as the hydrogen donor. The reaction afforded the corresponding chiral alcohol in both high yield and enantioselectivity, which was further converted in two steps into expected (5)-duloxetine, as shown in Scheme 9.17. 

In order to improve the performance of Noyori s catalytic system, Ru(II)-TsDPEN, which is very efficient but suffers from a long reaction time and a low activity in some cases, Mohar et al. have modified the diamine ligand by... 

Scheme 9.20 Ru-catalysed reductions of ketones with water-soluble analogues of Noyori s and Knochel s ligands.

TaniaPhos active catalyst discussion As shown by Salzer (2) such complexes with half sandwich stracture result in the catalyst cycle into a hydride species where the pentadienyl moiety can be hydrogenolyticaUy liberated (2, 6). This was verified in the case of BINAP complexes (2, diss. Podewils, Geyser). In accordance to this fact and other mechanistic aspects from Noyori s work (3, 5) it is likely that the pre-catalyst species undergoes the same reaction pathway and that the reactive part of the pre-catalyst, the pentadienyl moiety, will be liberated under hydrogenolytic conditions as shown below in Scheme 23.9 ... 

Scheme 1.22 Kitamura and Noyori s mechanism of the asymmetric addition of dialkyl zinc to aryl aldehydes.

Nonlinearity was also found for this asymmetric organozinc addition, for example, using 50% ee of chiral modifier 46 resulted in 80% ee of adduct 53. The enanti-oselectivity is also dependent on the reaction concentration >98% ee was obtained at 0.1-0.5 M but only 74% ee at 0.005 M. Kitamura and Noyori s work strongly suggested that heterodimer 72 might be more thermally stable than the homodimer... 

Scheme 15.7 Hydrogenation of unsaturated aldehydes using Noyori s system.

R. Noyori, S. Hashiguchi, T. Yamano, in Applied Homogeneous Catalysis with Orga-nometallic Compounds, 2nd ed. (Eds. 

Two technical applications of C = N-X substrates have been reported. Noyori s Ru-PP-NN catalyst system was successfully applied in a feasibility study by Dow Chirotech for the hydrogenation of a sulfonyl amidine [77], while Avecia showed the commercial viability of its CATHy catalyst based on a pentamethyl cyclopentadienyl Rh complex for the reduction of phosphinyl imines [78] (Fig. 34.11). 

The hydrogenation of a number of aromatic ketones is shown in Figure 37.30. Noyori s very effective Ru-diphosphine-diamine technology was developed by several companies. It is not clear on which scale the processes developed by Takasago (dm-binap = 3,5-xylyl-binap) [16] and Dow/Chirotech [109-111] for the reduction of substituted acetophenones are actually applied commercially. Using the Xyl-PhanePhos-dpen catalyst, a highly efficient bench-scale process was developed for the hydrogenation of p-fluoroacetophenone (ee 98%, TON 100000, TOF 50000 IT1 at r.t., 8 bar) [109]. Ru-P-Phos (licensed to Johnson Matthey [112]) achieved ee-values >99.9% and TON up to 100000 for sev-... 

Another interesting example is the supportation of Noyori s catalyst family containing Ru-chiral BINAP and chiral 1,2-diphenylethylenediamine [96]. These catalysts are suitable for the enantioselective hydrogenation of a variety of sub-... 

Fig. 42.12 I immobilization of Noyori s catalyst components on functionalized polystyrene.

Vedejs et al. reported catalyst inhibition during a study on the enantioselective transfer hydrogenation of dihydro-isoquinolines using Noyori s catalyst (Scheme 44.2) [27]. Here, the problem is caused by the bidentate nature of the substrate. Whereas the bromo compound 1 a could be rapidly reduced, the tosylamide-sub-stituted compound lb could not be reduced, and although the problem could be alleviated somewhat by alkylation of the sulfmamide to 1 c, hydrogenation of this was still sluggish. Although the authors propose this to be a case of product... 

Whereas most hydrogenation catalysts function very well in water (see for example Chapter 38 for two-phase aqueous catalysis), scattered instances are known of inhibition by water. Laue et al. attached Noyori s transfer hydrogenation catalyst to a soluble polymer and used this in a continuous device in which the catalyst was separated from the product by a membrane. The catalyst was found to be inhibited by the presence of traces of water in the feed stream, though this could be reversed by continuously feeding a small amount of potassium isopropoxide [60]. A case of water inhibition in iridium-catalyzed hydrogenation is described in Section 44.6.2. 

Jiang et al.113 synthesized another tridentate ligand 121 for asymmetric transfer hydrogenation. Ru-121-catalyzed asymmetric transfer hydrogenation gives comparable enantioselectivity to Noyori s catalyst 109 but shows more... 

A reductive intermolecular Heck heteroarylation (hydroheteroarylation) of A-protected azabicyclo[2,2,l]heptene 165 has been used to construct 7-azabicyclo[2.2.1]heptane 166 in moderate yield [131, 132]. An asymmetric version of such a transformation to provide enantiomerically-enriched iV-protected epibatidine has also been described [128, 133]. It was found that introduction of Noyori s BINAP ligand resulted in the best enantioselectivities with 72-81% ee and a 53% yield. By using either the (R)- or (S)-BINAP ligand, either enantiomer was easily accessible. 

---